))
The AOP Health Group is the European pioneer for integrated therapies for rare diseases and in critical care. Over the past 25 years, the Group has become an established provider of integrated therapy solutions and has a highly consistent and pragmatic orientation towards the needs of all its stakeholders– especially the patients and their families as well as also the healthcare professionals treating them.
…
continue reading
Research is Brainwork! What does that mean? How do pharmaceutical companies and academia collaborate to develop therapies for rare disease patients? And what skills are needed to work in this field? Find out and listen to Dr. Christoph Klade, Chief Scientific Officer at AOP Health, and Prof. Lukas Huber from the Medical University of Innsbruck talk…
…
continue reading
